Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer.
De Santis MC, Gozzelino L, Margaria JP, Costamagna A, Ratto E, Gulluni F, Di Gregorio E, Mina E, Lorito N, Bacci M, Lattanzio R, Sala G, Cappello P, Novelli F, Giovannetti E, Vicentini C, Andreani S, Delfino P, Corbo V, Scarpa A, Porporato PE, Morandi A, Hirsch E, Martini M. De Santis MC, et al. Among authors: gulluni f. Gut. 2023 Feb;72(2):360-371. doi: 10.1136/gutjnl-2021-325117. Epub 2022 May 27. Gut. 2023. PMID: 35623884 Free PMC article.
Targeting PI3K in Cancer: Any Good News?
Martini M, Ciraolo E, Gulluni F, Hirsch E. Martini M, et al. Among authors: gulluni f. Front Oncol. 2013 May 8;3:108. doi: 10.3389/fonc.2013.00108. eCollection 2013. Front Oncol. 2013. PMID: 23658859 Free PMC article.
PI3K/AKT signaling pathway and cancer: an updated review.
Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. Martini M, et al. Among authors: gulluni f. Ann Med. 2014 Sep;46(6):372-83. doi: 10.3109/07853890.2014.912836. Epub 2014 Jun 5. Ann Med. 2014. PMID: 24897931 Review.
Targeting PI3K signaling in cancer: Challenges and advances.
De Santis MC, Gulluni F, Campa CC, Martini M, Hirsch E. De Santis MC, et al. Among authors: gulluni f. Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):361-366. doi: 10.1016/j.bbcan.2019.03.003. Epub 2019 Apr 1. Biochim Biophys Acta Rev Cancer. 2019. PMID: 30946868 Review.
Phosphoinositides in cell proliferation and metabolism.
Hirsch E, Gulluni F, Martini M. Hirsch E, et al. Among authors: gulluni f. Adv Biol Regul. 2020 Jan;75:100693. doi: 10.1016/j.jbior.2020.100693. Epub 2020 Jan 20. Adv Biol Regul. 2020. PMID: 32008962 Review.
PI(3,4)P2 Signaling in Cancer and Metabolism.
Gozzelino L, De Santis MC, Gulluni F, Hirsch E, Martini M. Gozzelino L, et al. Among authors: gulluni f. Front Oncol. 2020 Mar 31;10:360. doi: 10.3389/fonc.2020.00360. eCollection 2020. Front Oncol. 2020. PMID: 32296634 Free PMC article. Review.
Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer.
Li H, Prever L, Hirsch E, Gulluni F. Li H, et al. Among authors: gulluni f. Cancers (Basel). 2021 Jul 14;13(14):3517. doi: 10.3390/cancers13143517. Cancers (Basel). 2021. PMID: 34298731 Free PMC article. Review.
Class II PI3K Functions in Cell Biology and Disease.
Gulluni F, De Santis MC, Margaria JP, Martini M, Hirsch E. Gulluni F, et al. Trends Cell Biol. 2019 Apr;29(4):339-359. doi: 10.1016/j.tcb.2019.01.001. Epub 2019 Jan 25. Trends Cell Biol. 2019. PMID: 30691999 Review.
Methods to measure the enzymatic activity of PI3Ks.
Ciraolo E, Gulluni F, Hirsch E. Ciraolo E, et al. Among authors: gulluni f. Methods Enzymol. 2014;543:115-40. doi: 10.1016/B978-0-12-801329-8.00006-4. Methods Enzymol. 2014. PMID: 24924130
21 results